Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

BK7508 Pharmaceutical Companies

Closed 07-28 16:00:00 AEST

476.48

+10.45

+2.24%

High476.70	Low465.83	Vol75.88M
Open467.69	D1 Closing466.03	Amplitude2.33%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O78.08M	T/O Rate--	Tradable Shares0.00
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":476.4826,"timestamp":1785218399937,"preClose":466.0288,"halted":0,"volume":75881285,"delay":0,"changeRate":0.022432,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":10.453796,"latestTime":"07-28 16:00:00 AEST","open":467.69324,"high":476.70444,"low":465.83255,"amount":78084309,"amplitude":0.023329,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1785283200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1785196800000,1785218400000]],"turnoverRate":0.002977,"increases":12,"decrements":15,"flats":16,"marketCap":66674939874,"floatMarketCap":63848746743.5},"requestUrl":"/m/hq/s/BK7508/tweets","defaultTab":"tweets","newsList":[{"id":"2654107193","title":"Why Retail Investors Are Tracking These Australian Founder Led Stocks Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2654107193","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654107193?lang=en_us&edition=fundamental","pubTime":"2026-07-28 12:43","pubTimestamp":1785213832,"startTime":"0","endTime":"0","summary":"Founder-led companies can be especially interesting when markets are shaped by big forces like energy prices, inflation, and shifting central bank policies. A founder who still owns a meaningful stake often has a long-term mindset and a direct financial incentive to manage through rate cycles, cost pressures, and uneven global growth. This Founder-Led Companies screener focuses on leaders who are personally invested in the outcome of their business. In this article you will see three of the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/why-retail-investors-are-tracking-these-australian-founder-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/why-retail-investors-are-tracking-these-australian-founder-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GEAR.AU","E200.AU","BK4211","IISV.AU","OZR.AU","BK7501","MAQ.AU","IIGF.AU","OZF.AU","BK7067","BK7042","BK7046","BK7508","XKO.AU","DACE.AU","IMLC.AU","MSB.AU","STW.AU","EIGA.AU","XJO.AU","SLF.AU","BK7043","QRE.AU","QFN.AU","GIVE.AU","VAP.AU","XAO.AU","ISBC","VAS.AU","FLT.AU","MQG.AU","BEAR.AU","BK7511","ZYAU.AU","BBOZ.AU","BK7070","IOZ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654022877","title":"CSL Says Topline Phase 3b Results Support Plan to Seek Expanded Pediatric Indication for Andembry","url":"https://stock-news.laohu8.com/highlight/detail?id=2654022877","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654022877?lang=en_us&edition=fundamental","pubTime":"2026-07-28 09:52","pubTimestamp":1785203526,"startTime":"0","endTime":"0","summary":"CSL's  Andembry drug showed a favorable safety and tolerability profile in a phase 3b study in children aged between two and 11 years with hereditary angioedema, a genetic disorder characterized by severe swelling, according to a late Monday statement.The company said it observed treatment response across the study population, with most of the participants remaining attack-free during the 12-month treatment period.The topline results support CSL's plan to seek an expanded pediatric indication for Andembry, and the company intends to start submitting filings to health authorities in the first half of its fiscal year.CSL shares gained 1% in recent Tuesday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SGXZ23171101.USD","BK7511","BK7501","SG9999004303.SGD","BK7067","BK7508","BK4086","LU1169590202.USD","CSL.AU","LU0728928796.USD","LU1169589451.USD","CSL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654960021","title":"Clinuvel Pharmaceuticals Plans to Report Late-Stage Vitiligo Study Topline Results in December","url":"https://stock-news.laohu8.com/highlight/detail?id=2654960021","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654960021?lang=en_us&edition=fundamental","pubTime":"2026-07-28 08:38","pubTimestamp":1785199132,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals  is completing its first late-stage study of Scenesse in vitiligo, a condition that causes the loss of skin color, and expects to report topline results in December, according to a Tuesday filing with the Australian bourse.The trial has enrolled 210 patients globally, and its primary endpoint focuses on the proportion of patients who achieve a total body surface area response of equal to or greater than 50%, per the filing.The late-stage trial will be followed by a registration study that is expected to start in November, with a 12-month recruitment period planned, the company said.Clinuvel shares gained 1% in recent Tuesday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","CUV.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654026464","title":"Clinuvel Pharmaceuticals - Cuv105 Vitiligo Topline Results Expected in December 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2654026464","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654026464?lang=en_us&edition=fundamental","pubTime":"2026-07-28 06:57","pubTimestamp":1785193028,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nFWN43T155:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CUV.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654671048","title":"Andembry Showed Favorable Safety; Majority Remained Attack-Free During 12-Month Treatment Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2654671048","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654671048?lang=en_us&edition=fundamental","pubTime":"2026-07-27 21:00","pubTimestamp":1785157206,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA2NHVBF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7511","BK7501","CSL.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654304862","title":"CSL Reports Positive Top-Line Phase 3B Results Supporting Planned Expanded Pediatric Filing for Andembry® (Garadacimab-Gxii) in Children with Hereditary Angioedema (Hae)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654304862","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654304862?lang=en_us&edition=fundamental","pubTime":"2026-07-27 21:00","pubTimestamp":1785157206,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA2NHVBF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","CSL.AU","BK7501","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654048640","title":"To Submit Filings for Expanded Pediatric Indication for Andembry in First Half of Fiscal Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2654048640","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654048640?lang=en_us&edition=fundamental","pubTime":"2026-07-27 21:00","pubTimestamp":1785157206,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA2NHVBF:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","BK7501","BK7511","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654017922","title":"Immuron Posts CEO Presentation for TechKnow Invest Roadshow","url":"https://stock-news.laohu8.com/highlight/detail?id=2654017922","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654017922?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:04","pubTimestamp":1785153842,"startTime":"0","endTime":"0","summary":"Immuron posts CEO presentation for TechKnow Invest RoadshowImmuron published a CEO presentation for the TechKnow Invest Roadshow held today at Sofitel Melbourne on Collins.Presentation highlights Trav","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL8qcsxf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","IMC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654857097","title":"Anagenics Ltd-Change of Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2654857097","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654857097?lang=en_us&edition=fundamental","pubTime":"2026-07-27 14:55","pubTimestamp":1785135314,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUE1QLPCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AN1.AU","BK7508","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654093770","title":"Imugene Ltd Says Leslie Chong Resigns as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2654093770","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654093770?lang=en_us&edition=fundamental","pubTime":"2026-07-27 09:53","pubTimestamp":1785117224,"startTime":"0","endTime":"0","summary":"BRIEF-Imugene Ltd Says Leslie Chong Resigns As CEOJuly 27 (Reuters)-Imugene LtdIMU.AX:CEO RESIGNATIONLESLIE CHONG RESIGNS AS CEO OF IMUGENELESLIE CHONG STEPS DOWN AS MANAGING DIRECTOR AND CEO FOR PERSONAL REASONSFurther company coverage:IMU.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUE1D4RX7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","IMU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654933470","title":"Polynovo Keeps Bull Despite Revenue Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2654933470","media":"Dow Jones","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654933470?lang=en_us&edition=fundamental","pubTime":"2026-07-27 09:22","pubTimestamp":1785115320,"startTime":"0","endTime":"0","summary":"0122 GMT - PolyNovo keeps its bull at Macquarie despite the wound-treatment specialist missing FY 2026 revenue expectations. The investment bank maintains an outperform rating on the ASX-listed device maker, with analyst Shane Ponraj flagging a stronger-than-anticipated jump in annual cash flow from operations to A$24 million, from A$3 million. With a solid balance sheet and capital-expenditure requirements for PolyNovo's new manufacturing facility largely complete, Ponraj reckons that the company is now well-placed to invest in marketing. He expects ongoing strong order growth. Macquarie cuts its target price 26% to 1.30 Australian dollars. Shares are down 2.3% at A$0.835.  Dow Jones NewswiresJuly 26, 2026 21:22 ET Copyright  2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PNV.AU","BK7126","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654980830","title":"Imricor Medical Systems Hits 3-month High on Securing First US Hospital Customer","url":"https://stock-news.laohu8.com/highlight/detail?id=2654980830","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654980830?lang=en_us&edition=fundamental","pubTime":"2026-07-27 09:15","pubTimestamp":1785114926,"startTime":"0","endTime":"0","summary":"BUZZ-Imricor Medical Systems hits 3-month high on securing first US hospital customer** Imricor Medical Systems'IMR.AXshares rise as much as 9.9% to A$2.11, highest level since April 23** Medical tech company launches U.S. commercial operations and secures first hospital customer** Rady Children's Hospital in San Diego will purchase Imricor's NorthStar iMR mapping and guidance system, becoming the company's first commercial customer in the U.S.** About 769,000 shares change hands, 2.1x the 30-day average volume** Including session moves, stock up 30.1% this year","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL4N43T02B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IMR.AU","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654060709","title":"Imricor Medical Systems Begins US Commercial Launch with Sale of iMR Mapping, Guidance System","url":"https://stock-news.laohu8.com/highlight/detail?id=2654060709","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654060709?lang=en_us&edition=fundamental","pubTime":"2026-07-27 08:18","pubTimestamp":1785111524,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  began its official US commercial launch, with the Rady Children's Hospital in San Diego, California, purchasing its NorthStar interventional magnetic resonance  mapping and guidance system, according to a Monday Australian bourse filing.It also launched a new vertical, Imricor Cardiovascular, for the NorthStar system. It expects to continue adding devices and applications within the Cardiovascular business over time.Several US hospitals are in the final stages of the purchasing process, the filing added. Revenue from the NorthStar sales is expected to exceed the European business' aggregate full-year revenue in 2025.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","IMR.AU","BK7503","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654558060","title":"Imugene - Leslie Chong Resigns as CEO of Imugene","url":"https://stock-news.laohu8.com/highlight/detail?id=2654558060","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654558060?lang=en_us&edition=fundamental","pubTime":"2026-07-27 07:39","pubTimestamp":1785109176,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260726:nTUE1D4RX7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","IMU.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654060530","title":"Imugene Ltd-ceo Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=2654060530","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654060530?lang=en_us&edition=fundamental","pubTime":"2026-07-27 07:39","pubTimestamp":1785109176,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260726:nTUE1D4RX7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","IMU.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654809541","title":"Mesoblast Stock And 2 Australian Founder Led Companies Worth Watching","url":"https://stock-news.laohu8.com/highlight/detail?id=2654809541","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654809541?lang=en_us&edition=fundamental","pubTime":"2026-07-27 07:23","pubTimestamp":1785108238,"startTime":"0","endTime":"0","summary":"Founder led companies can offer something many investors value in a world of changing inflation, energy shocks and shifting rate expectations: leaders whose own legacy is tied to long term execution. While PMIs, housing data and tariff headlines pull markets in different directions, this screener focuses on businesses where the founder is still at the helm and personally invested in the outcome. That combination of ownership and accountability can appeal if you want management teams who stay...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/mesoblast-stock-and-2-australian-founder-led-companies-worth","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/mesoblast-stock-and-2-australian-founder-led-companies-worth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BBOZ.AU","GIVE.AU","BK7042","XJO.AU","ZYAU.AU","IISV.AU","MESO","E200.AU","XAO.AU","BK7511","BK7501","BK7070","DACE.AU","BK7046","VAS.AU","MAQ.AU","BK7067","VAP.AU","OZF.AU","FLT.AU","STW.AU","MSB.AU","IMLC.AU","XKO.AU","BK7043","EIGA.AU","SLF.AU","GEAR.AU","QFN.AU","IIGF.AU","IOZ.AU","MQG.AU","BEAR.AU","OZR.AU","QRE.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654067940","title":"Imricor Medical Systems, Inc-imricor Launches U.S. Commercial Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2654067940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654067940?lang=en_us&edition=fundamental","pubTime":"2026-07-27 06:34","pubTimestamp":1785105288,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260726:nTUEBTLYG8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMR.AU","BK7503","BK7007","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654675420","title":"WiseTech Global Stock and 2 Australian Shares Trading Below Estimated Fair Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2654675420","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654675420?lang=en_us&edition=fundamental","pubTime":"2026-07-27 03:18","pubTimestamp":1785093504,"startTime":"0","endTime":"0","summary":"With energy prices swinging, inflation signals mixed across regions and central banks rethinking policy, investors are paying closer attention to what really sits behind earnings and cash flow. The Undervalued Stocks Based On Cash Flows screener focuses on companies where discounted cash flow analysis suggests prices sit below fair value, so you are not relying only on short term sentiment. In a world of uneven housing data, shifting bond yields and fresh trade tariffs, that focus on cash...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/wisetech-global-stock-and-2-australian-shares-trading-below","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/wisetech-global-stock-and-2-australian-shares-trading-below","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EIGA.AU","DACE.AU","XAO.AU","GIVE.AU","ZYAU.AU","BK7507","BK4588","BK7501","OZR.AU","LYC.AU","GEAR.AU","SETM","SLF.AU","VAS.AU","QRE.AU","VAP.AU","IISV.AU","IIGF.AU","BEAR.AU","QFN.AU","WTC.AU","XKO.AU","OZF.AU","IMLC.AU","SPHQ","MSB.AU","BK7508","BK7503","BBOZ.AU","XJO.AU","BK4585","IOZ.AU","BK7067","BK7016","STW.AU","E200.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654067948","title":"3 ASX Growth Stocks Insiders Own With Up To 75% Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2654067948","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654067948?lang=en_us&edition=fundamental","pubTime":"2026-07-27 03:08","pubTimestamp":1785092895,"startTime":"0","endTime":"0","summary":"In the midst of heightened geopolitical tensions and fluctuating commodity prices, the Australian stock market is experiencing a slight downturn, influenced by new U.S. tariffs and rising oil prices. In such volatile conditions, growth companies with high insider ownership can offer unique insights into potential resilience and confidence in their future prospects.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice1-main-header/1585186555515","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice1-main-header/1585186555515"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-emr/emerald-resources-shares/news/3-asx-growth-stocks-insiders-own-with-up-to-75-revenue-growt","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-emr/emerald-resources-shares/news/3-asx-growth-stocks-insiders-own-with-up-to-75-revenue-growt","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IMLC.AU","QFN.AU","BK7062","AV1.AU","ERX","IOZ.AU","XJO.AU","EMR.AU","IISV.AU","DACE.AU","SLF.AU","SPL.AU","FRS.AU","OZF.AU","AWJ.AU","QRE.AU","BK4588","BK7508","BK7017","VDE","GEAR.AU","BK7096","VAP.AU","IIGF.AU","CAT.AU","PDI.AU","BK7110","SKS.AU","BK7104","GIVE.AU","OZR.AU","EIGA.AU","STW.AU","ZYAU.AU","BBOZ.AU","BEAR.AU","BK7501","XKO.AU","BK7023","E200.AU","BK7016","BTL.AU","VAS.AU","AR1.AU","BK7084","PNI.AU","BK7142","XAO.AU","TOR.AU","AEM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654067911","title":"King River Resources And 2 Other ASX Penny Stocks To Consider","url":"https://stock-news.laohu8.com/highlight/detail?id=2654067911","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654067911?lang=en_us&edition=fundamental","pubTime":"2026-07-27 03:01","pubTimestamp":1785092519,"startTime":"0","endTime":"0","summary":"The Australian stock market is experiencing a slight downturn, influenced by renewed U.S.-Iran tensions and rising oil prices. In such fluctuating conditions, investors often turn to penny stocks—companies that may be smaller or less established but can offer significant value when backed by solid financials. Despite the term's old-fashioned ring, these stocks remain relevant for those seeking opportunities in under-the-radar companies with potential for growth and stability.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-krr/king-river-resources-shares/news/king-river-resources-and-2-other-asx-penny-stocks-to-conside","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-krr/king-river-resources-shares/news/king-river-resources-and-2-other-asx-penny-stocks-to-conside","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MVP.AU","BK7096","TVN.AU","KRR.AU","BK7508","BK7095"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.0259},{"period":"3month","weight":0.0644},{"period":"6month","weight":0.0361},{"period":"1year","weight":0.1255},{"period":"ytd","weight":0.0459}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"name":"BK7508","nameEN":"BK7508"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmaceutical Companies(BK7508) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmaceutical Companies,BK7508,Pharmaceutical Companies股票,Pharmaceutical Companies股票老虎,Pharmaceutical Companies股票老虎国际,Pharmaceutical Companies行情,Pharmaceutical Companies股票行情,Pharmaceutical Companies股价,Pharmaceutical Companies股市,Pharmaceutical Companies股票价格,Pharmaceutical Companies股票交易,Pharmaceutical Companies股票购买,Pharmaceutical Companies股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmaceutical Companies(BK7508) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction